Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma

Key Points

• The study investigates the impact of IDH2 and TP53 mutations on the survival of patients with chondrosarcoma.
• Analysis of mutation frequency in dedifferentiated chondrosarcoma
• Assessment of survival data related to mutation status
• Evaluation of tumor grade influences
• IDH2 and TP53 mutations are significant, independent predictors of lower survival rates.
• Mutations were found to be enriched in dedifferentiated chondrosarcoma.
• Risk stratification may improve clinical decision-making based on mutation status.